CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		54,865,092
Beginning balance at Dec. 31, 2020	$ 453,266	$ 55	$ 650,300	$ 239	$ (197,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)		695,122
Issuance of common stock from the exercise of stock options and settlement of restricted stock units	1,849	$ 1	1,848
Stock-based compensation expense	3,909		3,909
Net income (loss)	8,650				8,650
Other comprehensive income (loss), net of tax	(47)			(47)
Ending balance (in shares) at Mar. 31, 2021		55,560,214
Ending balance at Mar. 31, 2021	467,627	$ 56	656,057	192	(188,678)
Beginning balance (in shares) at Dec. 31, 2020		54,865,092
Beginning balance at Dec. 31, 2020	453,266	$ 55	650,300	239	(197,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	18,303
Other comprehensive income (loss), net of tax	(136)
Ending balance (in shares) at Jun. 30, 2021		55,627,666
Ending balance at Jun. 30, 2021	481,220	$ 56	660,086	103	(179,025)
Beginning balance (in shares) at Mar. 31, 2021		55,560,214
Beginning balance at Mar. 31, 2021	467,627	$ 56	656,057	192	(188,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)		67,452
Issuance of common stock from the exercise of stock options and settlement of restricted stock units	289		289
Stock-based compensation expense	3,740		3,740
Net income (loss)	9,653				9,653
Other comprehensive income (loss), net of tax	(89)			(89)
Ending balance (in shares) at Jun. 30, 2021		55,627,666
Ending balance at Jun. 30, 2021	$ 481,220	$ 56	660,086	103	(179,025)
Beginning balance (in shares) at Dec. 31, 2021	55,900,855	55,900,855
Beginning balance at Dec. 31, 2021	$ 504,928	$ 56	669,223	(175)	(164,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)		585,857
Stock-based compensation expense	4,778		4,778
Net income (loss)	(6,430)				(6,430)
Other comprehensive income (loss), net of tax	(1,153)			(1,153)
Ending balance (in shares) at Mar. 31, 2022		56,486,712
Ending balance at Mar. 31, 2022	$ 502,123	$ 56	674,001	(1,328)	(170,606)
Beginning balance (in shares) at Dec. 31, 2021	55,900,855	55,900,855
Beginning balance at Dec. 31, 2021	$ 504,928	$ 56	669,223	(175)	(164,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(3,856)
Other comprehensive income (loss), net of tax	$ (1,256)
Ending balance (in shares) at Jun. 30, 2022	56,552,462	56,552,462
Ending balance at Jun. 30, 2022	$ 508,549	$ 57	677,955	(1,431)	(168,032)
Beginning balance (in shares) at Mar. 31, 2022		56,486,712
Beginning balance at Mar. 31, 2022	502,123	$ 56	674,001	(1,328)	(170,606)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)		65,750
Issuance of common stock from the exercise of stock options and settlement of restricted stock units	125	$ 1	124
Stock-based compensation expense	3,830		3,830
Net income (loss)	2,574				2,574
Other comprehensive income (loss), net of tax	$ (103)			(103)
Ending balance (in shares) at Jun. 30, 2022	56,552,462	56,552,462
Ending balance at Jun. 30, 2022	$ 508,549	$ 57	$ 677,955	$ (1,431)	$ (168,032)